168 related articles for article (PubMed ID: 30685248)
21. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009-2014.
Muñoz-Quiles C; López-Lacort M; Díez-Domingo J; Orrico-Sánchez A
BMC Infect Dis; 2020 Nov; 20(1):905. PubMed ID: 33256624
[TBL] [Abstract][Full Text] [Related]
22. The temporal impact of aging on the burden of herpes zoster.
Varghese L; Standaert B; Olivieri A; Curran D
BMC Geriatr; 2017 Jan; 17(1):30. PubMed ID: 28114907
[TBL] [Abstract][Full Text] [Related]
23. The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence.
Tseng HF; Bruxvoort K; Ackerson B; Luo Y; Tanenbaum H; Tian Y; Zheng C; Cheung B; Patterson BJ; Van Oorschot D; Sy LS
J Infect Dis; 2020 Aug; 222(5):798-806. PubMed ID: 31830250
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study.
Lu WH; Lin CW; Wang CY; Chen LK; Hsiao FY
BMC Public Health; 2018 Mar; 18(1):369. PubMed ID: 29554872
[TBL] [Abstract][Full Text] [Related]
25. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review.
Gater A; Uhart M; McCool R; Préaud E
BMC Public Health; 2015 Feb; 15():193. PubMed ID: 25880058
[TBL] [Abstract][Full Text] [Related]
26. Health care expenditure burden of persisting herpes zoster pain.
Dworkin RH; White R; O'Connor AB; Hawkins K
Pain Med; 2008 Apr; 9(3):348-53. PubMed ID: 18366512
[TBL] [Abstract][Full Text] [Related]
27. Economic burden of herpes zoster among skilled nursing facility residents in the United States.
Ma L; White RR; Narayanan S; Schmader KE
J Am Med Dir Assoc; 2012 Jan; 13(1):54-9. PubMed ID: 21450176
[TBL] [Abstract][Full Text] [Related]
28. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
29. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
30. Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK.
Matthews I; Duong M; Parsons VL; Nozad B; Qizilbash N; Patel Y; Guimicheva B
PLoS One; 2020; 15(2):e0229224. PubMed ID: 32097441
[TBL] [Abstract][Full Text] [Related]
31. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.
Sato K; Adachi K; Nakamura H; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Matsuki T; Kaise T; Gopala K; Holl K
J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531
[TBL] [Abstract][Full Text] [Related]
32. Herpes zoster in older adults: Impact on carbon footprint in the United States.
Curran D; Bitetti J; Catterall I; Wincott S
Hum Vaccin Immunother; 2024 Dec; 20(1):2335722. PubMed ID: 38698759
[TBL] [Abstract][Full Text] [Related]
33. Health care utilization and cost burden of herpes zoster in a community population.
Yawn BP; Itzler RF; Wollan PC; Pellissier JM; Sy LS; Saddier P
Mayo Clin Proc; 2009 Sep; 84(9):787-94. PubMed ID: 19720776
[TBL] [Abstract][Full Text] [Related]
34. Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
Kovac M; Lal H; Cunningham AL; Levin MJ; Johnson RW; Campora L; Volpi A; Heineman TC;
Vaccine; 2018 Mar; 36(12):1537-1541. PubMed ID: 29463421
[TBL] [Abstract][Full Text] [Related]
35. Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France.
Blein C; Gavazzi G; Paccalin M; Baptiste C; Berrut G; Vainchtock A
BMC Infect Dis; 2015 Aug; 15():350. PubMed ID: 26286598
[TBL] [Abstract][Full Text] [Related]
36. Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis.
Poirrier JE; Meyers JL; Nagar SP; Patterson BJ; Glasser LI; Jabbour SA
Diabetes Care; 2022 Nov; 45(11):2585-2593. PubMed ID: 36149780
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B
Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145
[TBL] [Abstract][Full Text] [Related]
38. Burden of venous leg ulcers in the United States.
Rice JB; Desai U; Cummings AK; Birnbaum HG; Skornicki M; Parsons N
J Med Econ; 2014 May; 17(5):347-56. PubMed ID: 24625244
[TBL] [Abstract][Full Text] [Related]
39. Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong.
You JHS; Ming WK; Lee CF; Tsang OT; Chan PK
Vaccine; 2018 Jul; 36(31):4610-4620. PubMed ID: 29958739
[TBL] [Abstract][Full Text] [Related]
40. A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.
Chen J; Abrahamson PE; Ke Y; Ong CR; Parikh R; Shantakumar S
Hum Vaccin Immunother; 2024 Dec; 20(1):2344983. PubMed ID: 38767209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
